Studie Hormone / Stoffwechsel

Growth Hormone Deficiency — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Growth Hormone Deficiency - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It a... mehr

Chronic Kidney Disease (Chronic Renal Failure) — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure), complete with latest updates, and... mehr

Growth Disorders — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Growth Disorders - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Growth Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv... mehr

Kidney Fibrosis — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Kidney Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Kidney Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involv... mehr

Urinary Incontinence — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Urinary Incontinence - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Urinary Incontinence, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key... mehr

TechNavio's analysts forecast the Global Endocrinology Drugs market to grow at a CAGR of 7.58 percent over the period 2012-2016. One of the key factors contributing to this market growth is the introduction of new drugs. The Global Endocrinology Drugs market has also been witnessing the increase in market consolidation. However, the off-label use of the human growth hormone could pose a challenge to the growth of this market.

mehr

Inguinal Hernia Global Clinical Trials Review, H1, 2013


Summary


GlobalData's clinical trial report, 'Inguinal Hernia Global Clinical Trials Review, H1, 2013' provides data on the Inguinal Hernia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inguinal Hernia. It includes an overview of the trial numbers and their recruitment status as per t... mehr

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD... mehr

Microalbuminuria — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Microalbuminuria - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Microalbuminuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv... mehr

Nocturia — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Nocturia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Nocturia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic... mehr

Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2012


Summary


GlobalData's clinical trial report, 'Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2012' provides data on the Focal Segmental Glomerulosclerosis (FSGS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Focal Segmental Glome... mehr

Hypoparathyroidism — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Hypoparathyroidism - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hypoparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key playe... mehr

Proteinuria — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Proteinuria - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Proteinuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the th... mehr

Thyroid Gland Disorders — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Thyroid Gland Disorders - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Thyroid Gland Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also re... mehr

Acute Renal Failure (ARF) (Acute Kidney Injury) — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with latest updates, ... mehr

Hypothyroidism Global Clinical Trials Review, H2, 2012


Summary


GlobalData's clinical trial report, 'Hypothyroidism Global Clinical Trials Review, H2, 2012' provides data on the Hypothyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypothyroidism. It includes an overview of the trial numbers and their recruitment status as per the s... mehr

Interstitial Cystitis (Painful Bladder Syndrome) — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome), complete with latest update... mehr

Other Genito Urinary Disorders — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Other Genito Urinary Disorders - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Other Genito Urinary Disorders, complete with latest updates, and special features on late-stage and discontinued... mehr

Urinary Retention Global Clinical Trials Review, H2, 2012


Summary


GlobalData's clinical trial report, 'Urinary Retention Global Clinical Trials Review, H2, 2012' provides data on the Urinary Retention clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Urinary Retention. It includes an overview of the trial numbers and their recruitment status ... mehr

Focal Segmental Glomerulosclerosis (FSGS) — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Focal Segmental Glomerulosclerosis (FSGS), complete with latest updates, and special featur... mehr

Glomerulonephritis — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Glomerulonephritis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Glomerulonephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key playe... mehr

Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2012


Summary


GlobalData's clinical trial report, 'Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2012' provides data on the Interstitial Cystitis (Painful Bladder Syndrome) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on ... mehr

Overactive Bladder — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Overactive Bladder - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Overactive Bladder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key playe... mehr

Polycystic Kidney Disease — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Polycystic Kidney Disease - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It a... mehr

Renal Failure — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Renal Failure - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Renal Failure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ... mehr

Bacteriuria Global Clinical Trials Review, H2, 2012


Summary


GlobalData's clinical trial report, 'Bacteriuria Global Clinical Trials Review, H2, 2012' provides data on the Bacteriuria clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacteriuria. It includes an overview of the trial numbers and their recruitment status as per the site of trial... mehr

Chronic Kidney Disease (Chronic Renal Failure) — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2012', provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure), c... mehr

Growth Disorders — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Growth Disorders - Pipeline Review, H2 2012', provides an overview of the Growth Disorders therapeutic pipeline. This report provides information on the therapeutic development for Growth Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players i... mehr

Kidney Disease — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Kidney Disease - Pipeline Review, H2 2012', provides an overview of the Kidney Disease therapeutic pipeline. This report provides information on the therapeutic development for Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ... mehr

Kidney Fibrosis — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Kidney Fibrosis - Pipeline Review, H2 2012', provides an overview of the Kidney Fibrosis therapeutic pipeline. This report provides information on the therapeutic development for Kidney Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players invol... mehr

Urinary Incontinence — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Urinary Incontinence - Pipeline Review, H2 2012', provides an overview of the Urinary Incontinence therapeutic pipeline. This report provides information on the therapeutic development for Urinary Incontinence, complete with latest updates, and special features on late-stage and discontinued projects. It also revie... mehr

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, 'Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2012' provides data on the Acute Renal Failure (ARF) (Acute Kidney Injury)/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to ... mehr

Microalbuminuria — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Microalbuminuria - Pipeline Review, H1 2012', provides an overview of the Microalbuminuria therapeutic pipeline. This report provides information on the therapeutic development for Microalbuminuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players i... mehr

Other Metabolic Disorders Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, 'Other Metabolic Disorders Global Clinical Trials Review, H1, 2012' provides data on the Other Metabolic Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Other Metabolic Disorders. It includes an overview of the trial numbe... mehr

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, ' Global Clinical Trials Review, H1, 2012' provides data on the Pre-Diabetes/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance. It includes an overview of... mehr

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) - Pipeline Review, H1 2012', provides an overview of the Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) therapeutic pipeline. This report provides information on the therapeutic development for Congenital Adrenal Hyp... mehr

Diabetic Gastroparesis Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, 'Diabetic Gastroparesis Global Clinical Trials Review, H1, 2012' provides data on the Diabetic Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Gastroparesis . It includes an overview of the trial numbers and thei... mehr

Gestational Diabetes Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, 'Gestational Diabetes Global Clinical Trials Review, H1, 2012' provides data on the Gestational Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gestational Diabetes. It includes an overview of the trial numbers and their recruit... mehr

Hypoparathyroidism — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Hypoparathyroidism - Pipeline Review, H1 2012', provides an overview of the Hypoparathyroidism therapeutic pipeline. This report provides information on the therapeutic development for Hypoparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p... mehr

Lupus Nephritis Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, 'Lupus Nephritis Global Clinical Trials Review, H1, 2012' provides data on the Lupus Nephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lupus Nephritis . It includes an overview of the trial numbers and their recruitment status as per ... mehr

Proteinuria — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Proteinuria - Pipeline Review, H1 2012', provides an overview of the Proteinuria therapeutic pipeline. This report provides information on the therapeutic development for Proteinuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the thera... mehr

Thyroid Gland Disorders — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Thyroid Gland Disorders - Pipeline Review, H1 2012', provides an overview of the Thyroid Gland Disorders therapeutic pipeline. This report provides information on the therapeutic development for Thyroid Gland Disorders, complete with latest updates, and special features on late-stage and discontinued projects. I... mehr

Acute Renal Failure (ARF) (Acute Kidney Injury) — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2012', provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) therapeutic pipeline. This report provides information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury... mehr

Cushing's Syndrome — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Cushing's Syndrome - Pipeline Review, H1 2012', provides an overview of the Cushing's Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Cushing's Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p... mehr

Growth Hormone Deficiency Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, 'Growth Hormone Deficiency Global Clinical Trials Review, H1, 2012' provides data on the Growth Hormone Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbe... mehr

Interstitial Cystitis (Painful Bladder Syndrome) — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2012', provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome) therapeutic pipeline. This report provides information on the therapeutic development for Interstitial Cystitis (Painful Bladder Synd... mehr

Nocturia — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Nocturia - Pipeline Review, H1 2012', provides an overview of the Nocturia therapeutic pipeline. This report provides information on the therapeutic development for Nocturia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic devel... mehr

Acromegaly — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Acromegaly - Pipeline Review, H1 2012', provides an overview of the Acromegaly therapeutic pipeline. This report provides information on the therapeutic development for Acromegaly, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeut... mehr

Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Endocrinology Market to 2018-Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients”, which provides insights into the endocri... mehr

Focal Segmental Glomerulosclerosis (FSGS) — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H1 2012', provides an overview of the Focal Segmental Glomerulosclerosis (FSGS) therapeutic pipeline. This report provides information on the therapeutic development for Focal Segmental Glomerulosclerosis (FSGS), complete with latest ... mehr

Glomerulonephritis — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Glomerulonephritis - Pipeline Review, H1 2012', provides an overview of the Glomerulonephritis therapeutic pipeline. This report provides information on the therapeutic development for Glomerulonephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p... mehr

Growth Hormone Deficiency — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Growth Hormone Deficiency - Pipeline Review, H1 2012', provides an overview of the Growth Hormone Deficiency therapeutic pipeline. This report provides information on the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued pro... mehr

Hyperoxaluria — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Hyperoxaluria - Pipeline Review, H1 2012', provides an overview of the Hyperoxaluria therapeutic pipeline. This report provides information on the therapeutic development for Hyperoxaluria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in t... mehr

Hyperparathyroidism — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Hyperparathyroidism - Pipeline Review, H1 2012', provides an overview of the Hyperparathyroidism therapeutic pipeline. This report provides information on the therapeutic development for Hyperparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews k... mehr

Lupus Nephritis — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Lupus Nephritis - Pipeline Review, H1 2012', provides an overview of the Lupus Nephritis therapeutic pipeline. This report provides information on the therapeutic development for Lupus Nephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players invol... mehr

Overactive Bladder — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Overactive Bladder - Pipeline Review, H1 2012', provides an overview of the Overactive Bladder therapeutic pipeline. This report provides information on the therapeutic development for Overactive Bladder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p... mehr

Polycystic Kidney Disease — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Polycystic Kidney Disease - Pipeline Review, H1 2012', provides an overview of the Polycystic Kidney Disease therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Kidney Disease, complete with latest updates, and special features on late-stage and discontinued pro... mehr

Growth Disorders — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Growth Disorders - Pipeline Review, H1 2012', provides an overview of the Growth Disorders therapeutic pipeline. This report provides information on the therapeutic development for Growth Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players i... mehr

Male Hypogonadism Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, 'Male Hypogonadism Global Clinical Trials Review, H1, 2012' provides data on the Male Hypogonadism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Male Hypogonadism. It includes an overview of the trial numbers and their recruitment status as per the s... mehr

Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Growth Hormone Deficiency (GHD) Therapeutics market. The repor... mehr

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, 'Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2012' provides data on the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer clinical trial scenario. This r... mehr

Bacteriuria Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Bacteriuria Global Clinical Trials Review, H2, 2011' provides data on the Bacteriuria clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacteriuria. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ... mehr

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2011' provides data on the Chronic Kidney Disease (Chronic Renal Failure) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Kidney Dis... mehr

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) - Pipeline Review, H2 2011', provides an overview of the Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) therapeutic pipeline. This report provides information on the therapeutic development for Congenital Adrenal Hyperplasia (Adrenoge... mehr

Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2011' provides data on the Focal Segmental Glomerulosclerosis (FSGS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Focal Segmental Glomerulosclerosi... mehr

Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the Industry analysis specialist, has released its new report, 'Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information on the global growth hormone deficiency therapeutics market, and provides analysis of a n... mehr

Hypoparathyroidism - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Hypoparathyroidism - Pipeline Review, H2 2011', provides an overview of the Hypoparathyroidism therapeutic pipeline. This report provides information on the therapeutic development for Hypoparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in... mehr

Interstitial Cystitis Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Interstitial Cystitis Global Clinical Trials Review, H2, 2011' provides data on the Interstitial Cystitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Interstitial Cystitis. It includes an overview of the trial numbers and their recruitment sta... mehr

Proteinuria - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Proteinuria - Pipeline Review, H2 2011', provides an overview of the Proteinuria therapeutic pipeline. This report provides information on the therapeutic development for Proteinuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development... mehr

Thyroid Gland Disorders - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Thyroid Gland Disorders - Pipeline Review, H2 2011', provides an overview of the Thyroid Gland Disorders therapeutic pipeline. This report provides information on the therapeutic development for Thyroid Gland Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key... mehr

Urinary Retention Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Urinary Retention Global Clinical Trials Review, H2, 2011' provides data on the Urinary Retention clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Urinary Retention. It includes an overview of the trial numbers and their recruitment status as per the s... mehr

Acromegaly - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Acromegaly - Pipeline Review, H2 2011', provides an overview of the Acromegaly therapeutic pipeline. This report provides information on the therapeutic development for Acromegaly, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for... mehr

Benign Prostatic Hyperplasia (BPH) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Benign Prostatic Hyperplasia (BPH) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global BPH market. The report identifies the key trends shaping... mehr

Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2011', provides an overview of the Focal Segmental Glomerulosclerosis (FSGS) therapeutic pipeline. This report provides information on the therapeutic development for Focal Segmental Glomerulosclerosis (FSGS), complete with latest updates, and speci... mehr

Glomerulonephritis - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Glomerulonephritis - Pipeline Review, H2 2011', provides an overview of the Glomerulonephritis therapeutic pipeline. This report provides information on the therapeutic development for Glomerulonephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in... mehr

Growth Hormone Deficiency - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Growth Hormone Deficiency - Pipeline Review, H2 2011', provides an overview of the Growth Hormone Deficiency therapeutic pipeline. This report provides information on the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also rev... mehr

Growth Hormone Deficiency Global Clinical Trials Review, H2 2011

Summary

GlobalData's clinical trial report, 'Growth Hormone Deficiency Global Clinical Trials Review, H2, 2011' provides data on the Growth Hormone Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their ... mehr

Hyperoxaluria - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Hyperoxaluria - Pipeline Review, H2 2011', provides an overview of the Hyperoxaluria therapeutic pipeline. This report provides information on the therapeutic development for Hyperoxaluria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic dev... mehr

Hyperparathyroidism - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Hyperparathyroidism - Pipeline Review, H2 2011', provides an overview of the Hyperparathyroidism therapeutic pipeline. This report provides information on the therapeutic development for Hyperparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involve... mehr

Lupus Nephritis - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Lupus Nephritis - Pipeline Review, H2 2011', provides an overview of the Lupus Nephritis therapeutic pipeline. This report provides information on the therapeutic development for Lupus Nephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therape... mehr

Overactive Bladder - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Overactive Bladder - Pipeline Review, H2 2011', provides an overview of the Overactive Bladder therapeutic pipeline. This report provides information on the therapeutic development for Overactive Bladder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in... mehr

Polycystic Kidney Disease - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Polycystic Kidney Disease - Pipeline Review, H2 2011', provides an overview of the Polycystic Kidney Disease therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also rev... mehr

Growth Disorders - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Growth Disorders - Pipeline Review, H2 2011', provides an overview of the Growth Disorders therapeutic pipeline. This report provides information on the therapeutic development for Growth Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the the... mehr

Male Hypogonadism - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Male Hypogonadism - Pipeline Review, H2 2011', provides an overview of the Male Hypogonadism therapeutic pipeline. This report provides information on the therapeutic development for Male Hypogonadism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the... mehr

Post-Menopausal Hormone Replacement Therapy (HRT) - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Post-Menopausal Hormone Replacement Therapy (HRT) - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Post-Menopausal Hormone Replacement Therapy (HRT) ma... mehr

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2011', provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) therapeutic pipeline. This report provides information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with l... mehr

Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2011' provides data on the Benign Prostatic Hyperplasia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Benign Prostatic Hyperplasia. It includes an overview of the trial numbe... mehr

Cushing's Syndrome - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Cushing's Syndrome - Pipeline Review, H2 2011', provides an overview of the Cushing's Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Cushing's Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in... mehr

Hypothyroidism Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Hypothyroidism Global Clinical Trials Review, H2, 2011' provides data on the Hypothyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypothyroidism. It includes an overview of the trial numbers and their recruitment status as per the site of trial... mehr

Interstitial Cystitis - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Interstitial Cystitis - Pipeline Review, H2 2011', provides an overview of the Interstitial Cystitis therapeutic pipeline. This report provides information on the therapeutic development for Interstitial Cystitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players... mehr

Nocturia - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Nocturia - Pipeline Review, H2 2011', provides an overview of the Nocturia therapeutic pipeline. This report provides information on the therapeutic development for Nocturia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Nocturi... mehr

Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, 'Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011' provides data on the Growth Hormone Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their... mehr

Hyperparathyroidism Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, 'Hyperparathyroidism Global Clinical Trials Review, Q2, 2011' provides data on the Hyperparathyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperparathyroidism. It includes an overview of the trial numbers and their recruitment status as p... mehr

Hypothyroidism Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, 'Hypothyroidism Global Clinical Trials Review, Q2, 2011' provides data on the Hypothyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypothyroidism. It includes an overview of the trial numbers and their recruitment status as per the site of trial... mehr

Congenital Adrenal Hyperplasia - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Congenital Adrenal Hyperplasia - Pipeline Review, Q2 2011', provides an overview of the Congenital Adrenal Hyperplasia therapeutic pipeline. This report provides information on the therapeutic development for Congenital Adrenal Hyperplasia, complete with latest updates, and special features on late-stage and discontinued p... mehr

Hypoparathyroidism - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Hypoparathyroidism - Pipeline Review, Q2 2011', provides an overview of the Hypoparathyroidism therapeutic pipeline. This report provides information on the therapeutic development for Hypoparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in... mehr

Proteinuria - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Proteinuria - Pipeline Review, Q2 2011', provides an overview of the Proteinuria therapeutic pipeline. This report provides information on the therapeutic development for Proteinuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development... mehr

Thyroid Gland Disorders - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Thyroid Gland Disorders - Pipeline Review, Q2 2011', provides an overview of the Thyroid Gland Disorders therapeutic pipeline. This report provides information on the therapeutic development for Thyroid Gland Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key... mehr

Acute Renal Failure (ARF) - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Acute Renal Failure (ARF) - Pipeline Review, Q2 2011', provides an overview of the Acute Renal Failure (ARF) therapeutic pipeline. This report provides information on the therapeutic development for Acute Renal Failure (ARF), complete with latest updates, and special features on late-stage and discontinued projects. It also rev... mehr

Cushing's Syndrome - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Cushing's Syndrome - Pipeline Review, Q2 2011', provides an overview of the Cushing's Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Cushing's Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in... mehr

Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market

Summary

GBI Research has released its pharmaceutical research, 'Gout Therapeutics Market to 2017 - Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market”, which provides insights into gout therapeutics sales and price forecasts until 2017. The report also de... mehr

Interstitial Cystitis - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Interstitial Cystitis - Pipeline Review, Q2 2011', provides an overview of the Interstitial Cystitis therapeutic pipeline. This report provides information on the therapeutic development for Interstitial Cystitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players... mehr

Nocturia - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Nocturia - Pipeline Review, Q2 2011', provides an overview of the Nocturia therapeutic pipeline. This report provides information on the therapeutic development for Nocturia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Nocturi... mehr

Acromegaly And Gigantism (Growth Hormone Disorders) - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Acromegaly And Gigantism (Growth Hormone Disorders) - Pipeline Review, Q1 2011', provides an overview of the Acromegaly And Gigantism (Growth Hormone Disorders) therapeutic pipeline. This report provides information on the therapeutic development for Acromegaly And Gigantism (Growth Hormone Disorders),... mehr

Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, Q1 2011', provides an overview of the Focal Segmental Glomerulosclerosis (FSGS) therapeutic pipeline. This report provides information on the therapeutic development for Focal Segmental Glomerulosclerosis (FSGS), complete with latest updates, and speci... mehr

Glomerulonephritis - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Glomerulonephritis - Pipeline Review, Q1 2011', provides an overview of the Glomerulonephritis therapeutic pipeline. This report provides information on the therapeutic development for Glomerulonephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in... mehr

Glomerulonephritis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Glomerulonephritis Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global glomerulonephritis therapeutics market. The report identifies the key trends shaping and... mehr

Growth Hormone Deficiency - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Growth Hormone Deficiency - Pipeline Review, Q1 2011', provides an overview of the Growth Hormone Deficiency therapeutic pipeline. This report provides information on the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also rev... mehr

Hyperoxaluria - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Hyperoxaluria - Pipeline Review, Q1 2011', provides an overview of the Hyperoxaluria therapeutic pipeline. This report provides information on the therapeutic development for Hyperoxaluria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic dev... mehr

Hyperparathyroidism - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Hyperparathyroidism - Pipeline Review, Q1 2011', provides an overview of the Hyperparathyroidism therapeutic pipeline. This report provides information on the therapeutic development for Hyperparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involve... mehr

Lupus Nephritis - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Lupus Nephritis - Pipeline Review, Q1 2011', provides an overview of the Lupus Nephritis therapeutic pipeline. This report provides information on the therapeutic development for Lupus Nephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therape... mehr

Lupus Nephritis Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Lupus Nephritis Global Clinical Trials Review, Q1, 2011' provides data on the Lupus Nephritis clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Lupus Nephritis . It includes an overview of the trial numbers and their recruitment status as per the site of ... mehr

Overactive Bladder - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Overactive Bladder - Pipeline Review, Q1 2011', provides an overview of the Overactive Bladder therapeutic pipeline. This report provides information on the therapeutic development for Overactive Bladder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in... mehr

Polycystic Kidney Disease - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Polycystic Kidney Disease - Pipeline Review, Q1 2011', provides an overview of the Polycystic Kidney Disease therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also rev... mehr

Benign Prostatic Hyperplasia - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Benign Prostatic Hyperplasia - Pipeline Review, Q1 2011', provides an overview of the Benign Prostatic Hyperplasia therapeutic pipeline. This report provides information on the therapeutic development for Benign Prostatic Hyperplasia, complete with latest updates, and special features on late-stage and discontinued projects.... mehr

The market for calming and sleeping products experienced moderate growth during 2010, with year-on-year growth of just over 7%. The rising number of elderly people in China has driven demand for these kinds of products. However, since many health food products also claim to provide similar functions to calming and sleeping products in China, the OTC market for such products has come under considerable pressure and therefore registered o... mehr

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, Q1 2011', provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure), complete with lates... mehr

Diabetes Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Diabetes Global Clinical Trials Review, Q1, 2011' provides data on the Diabetes clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Diabetes. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout ... mehr

Diabetic Foot Infection (DFI) Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Diabetic Foot Infection (DFI) Global Clinical Trials Review, Q1, 2011' provides data on the Diabetic Foot Infection (DFI) Global clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Diabetic Foot Infection (DFI) . It includes an overview of the... mehr

Diabetic Foot Ulcers Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Diabetic Foot Ulcers Global Clinical Trials Review, Q1, 2011' provides data on the Diabetic Foot Ulcers clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Diabetic Foot Ulcers . It includes an overview of the trial numbers and their recruitment status ... mehr

Diabetic Gastroparesis Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Diabetic Gastroparesis Global Clinical Trials Review, Q1, 2011' provides data on the Diabetic Gastroparesis Global clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Diabetic Gastroparesis . It includes an overview of the trial numbers and their rec... mehr

Diabetic Ketoacidosis Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Diabetic Ketoacidosis Global Clinical Trials Review, Q1, 2011' provides data on the Diabetic Ketoacidosis Global clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Diabetic Ketoacidosis. It includes an overview of the trial numbers and their recruitm... mehr

Gestational Diabetes Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Gestational Diabetes Global Clinical Trials Review, Q1, 2011' provides data on the Gestational Diabetes Global clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Gestational Diabetes . It includes an overview of the trial numbers and their recruitment... mehr

Glucose Intolerance Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Glucose Intolerance Global Clinical Trials Review, Q1, 2011' provides data on the Glucose Intolerance Global clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Glucose Intolerance. It includes an overview of the trial numbers and their recruitment stat... mehr

Growth Disorders - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Growth Disorders - Pipeline Review, Q1 2011', provides an overview of the Growth Disorders therapeutic pipeline. This report provides information on the therapeutic development for Growth Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the the... mehr

Hyperglycemia Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Hyperglycemia Global Clinical Trials Review, Q1, 2011' provides data on the Hyperglycemia Global clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Hyperglycemia . It includes an overview of the trial numbers and their recruitment status as per the site of t... mehr

Hypoglycemia Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Hypoglycemia Global Clinical Trials Review, Q1, 2011' provides data on the Hypoglycemia Global clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Hypoglycemia . It includes an overview of the trial numbers and their recruitment status as per the site of trial... mehr

Obesity Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Obesity Global Clinical Trials Review, Q1, 2011' provides data on the obesity clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on obesity . It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the... mehr

Urinary Incontinence - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Urinary Incontinence - Pipeline Review, Q1 2011', provides an overview of the Urinary Incontinence therapeutic pipeline. This report provides information on the therapeutic development for Urinary Incontinence, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv... mehr

Growth Hormone Deficiency (GHD) - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData’s report, 'Growth Hormone Deficiency - Pipeline Assessment and Market Forecasts to 2017”, is an essential source of information and analysis on the global groeth hormone deficiency (GHD) market. The report identifies the key trends shaping and driving the global GHD market. The report also provides insights int... mehr

Introduction

Sales of hormone replacement therapies treating menopausal symptoms have seen a sharp decline in recent years as a result of safety concerns raised by the Women's Health Initiative (WHI) study in 2002. Coupling this with Pfizer's acquisition of Wyeth, the leading estrogen manufacturer, the future direction of the market is uncertain.

Reasons to Purchase

* Understand the current and futur... mehr

Introduction

Sales of hormone replacement therapies treating menopausal symptoms have seen a sharp decline in recent years as a result of safety concerns raised by the Women's Health Initiative (WHI) study in 2002. Coupling this with Pfizer's acquisition of Wyeth, the leading estrogen manufacturer, the future direction of the market is uncertain.

Reasons to Purchase

* Understand the current and futur... mehr

Introduction

Sales of hormone replacement therapies treating menopausal symptoms have seen a sharp decline in recent years as a result of safety concerns raised by the Women's Health Initiative (WHI) study in 2002. Coupling this with Pfizer's acquisition of Wyeth, the leading estrogen manufacturer, the future direction of the market is uncertain.
Scope

* Patient potential analysis across the seven major ma... mehr

Introduction

Sales of hormone replacement therapies treating menopausal symptoms have seen a sharp decline in recent years as a result of safety concerns raised by the Women's Health Initiative (WHI) study in 2002. Coupling this with Pfizer's acquisition of Wyeth, the leading estrogen manufacturer, the future direction of the market is uncertain.
Scope

* Patient potential analysis across the seven major ma... mehr

Introduction

The testosterone replacement therapy market grew with an impressive compound annual growth rate [CAGR]: 24.3% from 2005 to 2009 to reach $838m sales. While these drugs can reverse the symptoms of testosterone deficiency rather efficaciously, only an estimated 5% of affected people receive treatment.
Scope

* Patient potential analysis across the seven major markets
* Review of the key ... mehr

Introduction

The testosterone replacement therapy market grew with an impressive compound annual growth rate [CAGR]: 24.3% from 2005 to 2009 to reach $838m sales. While these drugs can reverse the symptoms of testosterone deficiency rather efficaciously, only an estimated 5% of affected people receive treatment.
Scope

* Patient potential analysis across the seven major markets
* Review of the key ... mehr

Introduction

The testosterone replacement therapy market grew with an impressive compound annual growth rate [CAGR]: 24.3% from 2005 to 2009 to reach $838m sales. While these drugs can reverse the symptoms of testosterone deficiency rather efficaciously, only an estimated 5% of affected people receive treatment.

Reasons to Purchase

* Understand the current and future market size and dynamics
... mehr

Introduction

The testosterone replacement therapy market grew with an impressive compound annual growth rate [CAGR]: 24.3% from 2005 to 2009 to reach $838m sales. While these drugs can reverse the symptoms of testosterone deficiency rather efficaciously, only an estimated 5% of affected people receive treatment.

Reasons to Purchase

* Understand the current and future market size and dynamics
... mehr

Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData's has released its pharmaceutical and healthcare report, 'Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global menopause hormone therapy market. The report identifies the key trends shapin... mehr

The number of people migrating to large cities like Hanoi, Danang, and Ho Chi Minh City continued to increase during 2009 and urban noise and air pollution is becoming and ever larger problem in Vietnam. Moreover, the population density in large cities such as Ho Chi Minh City is very high, causing traffic jams and high levels of smoke and dirt which are causing throat, lung, and nose related health problems.

Euromonitor Inte... mehr

Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist’s new report, 'Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global growth hormone deficiency market. The report identifies the key trends shaping and driving the global growth hormone d... mehr

Life Science Analytics', Growth Hormone Deficiency Therapy Area Pipeline Report contains detailed information on the growth hormone deficiency drug pipeline. This report provides insight into the pipeline status of growth hormone deficiency drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Re... mehr

Life Science Analytics', Hormone Replacement Therapy Therapy Area Pipeline Report contains detailed information on the hormone replacement therapy drug pipeline. This report provides insight into the pipeline status of hormone replacement therapy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipel... mehr

Life Science Analytics', Hyperthyroidism Therapy Area Pipeline Report contains detailed information on the hyperthyroidism drug pipeline. This report provides insight into the pipeline status of hyperthyroidism drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with re... mehr

Life Science Analytics', Hypogonadism Therapy Area Pipeline Report contains detailed information on the hypogonadism drug pipeline. This report provides insight into the pipeline status of hypogonadism drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail... mehr

Introduction

Since the 1960s, hormonal contraceptives have been widely used as effective birth control in the developed world. Although they are mainly used to prevent pregnancies, they can be used for treating other conditions such as acne, endometriosis, and polycystic ovarian syndrome. In 2008, the hormonal contraceptives market was worth $6.2 billion across the seven major pharmaceutical countries.

Reasons to P... mehr

Life Science Analytics', 'Metabolic Endocrinology Growth Hormone Deficiency ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real deta... mehr

Life Science Analytics', 'Metabolic Endocrinology Hormone Replacement Therapy ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real de... mehr

Life Science Analytics', 'Metabolic Endocrinology Hypercalcemia ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug p... mehr

Life Science Analytics', 'Metabolic Endocrinology Hypocalcemia ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pi... mehr

Life Science Analytics', 'Metabolic Endocrinology Hypogonadism ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pi... mehr